Cargando…
Risk and surrogate benefit for pediatric Phase I trials in oncology: A systematic review with meta-analysis
BACKGROUND: Pediatric Phase I cancer trials are critical for establishing the safety and dosing of anti-cancer treatments in children. Their implementation, however, must contend with the rarity of many pediatric cancers and limits on allowable risk in minors. The aim of this study is to describe th...
Autores principales: | Waligora, Marcin, Bala, Malgorzata M., Koperny, Magdalena, Wasylewski, Mateusz T., Strzebonska, Karolina, Jaeschke, Rafał R., Wozniak, Agnieszka, Piasecki, Jan, Sliwka, Agnieszka, Mitus, Jerzy W., Polak, Maciej, Nowis, Dominika, Fergusson, Dean, Kimmelman, Jonathan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5819765/ https://www.ncbi.nlm.nih.gov/pubmed/29462168 http://dx.doi.org/10.1371/journal.pmed.1002505 |
Ejemplares similares
-
Clinical development success rates and social value of pediatric Phase 1 trials in oncology
por: Wasylewski, Mateusz T., et al.
Publicado: (2020) -
Risk and benefit for umbrella trials in oncology: a systematic review and meta-analysis
por: Strzebonska, Karolina, et al.
Publicado: (2022) -
Risk and Benefit for Targeted Therapy Agents in Pediatric Phase II Trials in Oncology: A Systematic Review with a Meta-Analysis
por: Strzebonska, Karolina, et al.
Publicado: (2021) -
Umbrella and basket trials in oncology: ethical challenges
por: Strzebonska, Karolina, et al.
Publicado: (2019) -
Results dissemination of registered clinical trials across Polish academic institutions: a cross-sectional analysis
por: Strzebonska, Karolina, et al.
Publicado: (2020)